(Q34537570)

2 August 2017

0 references

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Faris R

1

1 reference

2 August 2017

Flather M

2

1 reference

2 August 2017

Purcell H

3

1 reference

2 August 2017

Henein M

4

1 reference

2 August 2017

Poole-Wilson P

5

1 reference

2 August 2017

Coats A

6

1 reference

2 August 2017

publication date

1 February 2002

1 reference

International Journal of Cardiology

2 August 2017

published in

1 reference

2 August 2017

volume

82

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

149-158

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

THE DIURETIC RESPONSE TO FRUSEMIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

The effects of discontinuing long-term diuretic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Unnecessary diuretic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Short term effect of withdrawal of diuretic drugs prescribed for ankle oedema

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

[Basic therapy of chronic heart failure with digitalis or diuretics?]

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

A 3-month double-blind cross-over study of the effect of benazepril and hydrochlorothiazide on functional class in symptomatic mild heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

Clinical experience with chlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900600-3

7 January 2021

10.1016/S0167-5273(01)00600-3

Identifiers

DOI

1 reference

2 August 2017

1 reference